HSBC Holdings
MBII

HSBC Holdings’s Marrone Bio Innovations, Inc. MBII Stock Holding History

HSBC Holdings’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,228
Closed -$17K – 3551
2021
Q4 		$17K Hold
24,228
– – ﹤0.01% 3231
2021
Q3 		$21K Hold
24,228
– – ﹤0.01% 2954
2021
Q2 		$41K Buy
24,228
+13,852
+134% +$23.2K ﹤0.01% 2892
2021
Q1 		$20K Buy
+10,376
New +$21.6K ﹤0.01% 2681

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HSBC Holdings's MBII Position: Q1 2022 in Review

HSBC Holdings sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 24,228 shares — an estimated $17K sold.

HSBC Holdings first reported a position in MBII in Q1 2021 and held it in 4 quarters. The position peaked at $41K in Q2 2021. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • HSBC Holdings reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • HSBC Holdings sold 24,228 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $17K.
  • HSBC Holdings first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 4 quarters.
  • HSBC Holdings's Marrone Bio Innovations, Inc. position peaked at $41K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on HSBC Holdings's 13F filing for Q1 2022, filed 16 May 2022.